447 related articles for article (PubMed ID: 20864366)
1. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA
Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366
[TBL] [Abstract][Full Text] [Related]
2. Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase.
Huang HC; Hu CH; Tang MC; Wang WS; Chen PM; Su Y
Oncogene; 2007 Apr; 26(19):2781-90. PubMed ID: 17072345
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
[TBL] [Abstract][Full Text] [Related]
4. Thymosin β4 induces invasion and migration of human colorectal cancer cells through the ILK/AKT/β-catenin signaling pathway.
Piao Z; Hong CS; Jung MR; Choi C; Park YK
Biochem Biophys Res Commun; 2014 Sep; 452(3):858-64. PubMed ID: 25218472
[TBL] [Abstract][Full Text] [Related]
5. Thymosin β4 induces proliferation, invasion, and epithelial-to-mesenchymal transition of oral squamous cell carcinoma.
Hong KO; Lee JI; Hong SP; Hong SD
Amino Acids; 2016 Jan; 48(1):117-27. PubMed ID: 26276576
[TBL] [Abstract][Full Text] [Related]
6. Association of thymosin β4 expression with clinicopathological parameters and clinical outcomes of bladder cancer patients.
Wang ZY; Zhang W; Yang JJ; Song DK; Wei JX; Gao S
Neoplasma; 2016; 63(6):991-998. PubMed ID: 27596300
[TBL] [Abstract][Full Text] [Related]
7. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
[TBL] [Abstract][Full Text] [Related]
8. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
[TBL] [Abstract][Full Text] [Related]
9. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
10. MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.
Wu CL; Ho JY; Chou SC; Yu DS
Oncotarget; 2016 May; 7(18):26593-603. PubMed ID: 27058893
[TBL] [Abstract][Full Text] [Related]
11. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
12. The effect of Pokemon on bladder cancer epithelial-mesenchymal transition.
Guo C; Zhu K; Sun W; Yang B; Gu W; Luo J; Peng B; Zheng J
Biochem Biophys Res Commun; 2014 Jan; 443(4):1226-31. PubMed ID: 24393848
[TBL] [Abstract][Full Text] [Related]
13. Integrin-linked kinase regulates cadherin switch in bladder cancer.
Gil D; Ciołczyk-Wierzbicka D; Dulińska-Litewka J; Laidler P
Tumour Biol; 2016 Nov; 37(11):15185-15191. PubMed ID: 27683053
[TBL] [Abstract][Full Text] [Related]
14. Dual role of TGFBR3 in bladder cancer.
Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
[TBL] [Abstract][Full Text] [Related]
15. Thymosin β4 promotes hepatoblastoma metastasis via the induction of epithelial-mesenchymal transition.
Fu X; Cui P; Chen F; Xu J; Gong L; Jiang L; Zhang D; Xiao Y
Mol Med Rep; 2015 Jul; 12(1):127-32. PubMed ID: 25695679
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
[TBL] [Abstract][Full Text] [Related]
17. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma.
Liang PY; Li HY; Zhou ZY; Jin YX; Wang SX; Peng XH; Ou SJ
Tumour Biol; 2013 Jun; 34(3):1783-91. PubMed ID: 23483488
[TBL] [Abstract][Full Text] [Related]
19. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
20. nm23-H1 is a negative regulator of TGF-β1-dependent induction of epithelial-mesenchymal transition.
Zhao R; Gong L; Li L; Guo L; Zhu D; Wu Z; Zhou Q
Exp Cell Res; 2013 Mar; 319(5):740-9. PubMed ID: 23137649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
